Regeneron, Bayer's Eylea works in two-year study of diabetic eye disease
Regeneron Pharmaceuticals and Bayer’s drug Eylea helped improve conditions of patients suffering from a diabetic eye disease in a two-year study.
Regeneron Pharmaceuticals and Bayer’s drug Eylea helped improve conditions of patients suffering from a diabetic eye disease in a two-year study.